TY - JOUR
T1 - Economics of Emergency Department Visits by Patients With Inflammatory Bowel Disease
T2 - A Real-World Analysis
AU - Clarke, Kofi
AU - Momin, Arsh
AU - Rosario, Michelle
AU - Stuart, August
AU - Dalessio, Shannon
AU - Tinsley, Andrew
AU - Williams, Emmanuelle
AU - Coates, Matthew
N1 - Publisher Copyright:
© 2024 Oxford University Press. All rights reserved.
PY - 2024/4/1
Y1 - 2024/4/1
N2 - Background: Inflammatory bowel disease (IBD) is associated with significant psychosocial, economic, and physical burden on patients. IBD care in the United States results in significant healthcare expenditure with recurring emergency department (ED) care and hospital admissions. Despite advances in therapy and improved access to specialty care, there is still room for improvement in cost-efficient care. Specialty medical homes and interdisciplinary care models have emerged as ways to improve medical care, patient outcomes, and quality of life, as well as improve the impact of healthcare costs. There is limited real-world data on cost in the United States, with many articles citing cost estimates from models. Methods: We analyzed real-world data from our tertiary care center with a focus on recurrent ED visits by IBD patients. Descriptive statistics were used for a cost analysis of multiple ED visits by IBD patients. Patients with ≥4 visits to the ED in a 6-month period were described as SuperUsers and were included in a separate analysis. The cost of hospitalization was also included. Results: Total cost associated with all ED visits from SuperUsers were $72 999.57 with an average of $6636.32 per patient. When the patients were admitted, the total cost of ED visits and hospitalizations was $721 461.52, with an average of $65 587.41 per patient. Conclusions: ED utilization by IBD patients with or without hospitalization is expensive and is typically driven by a cohort of SuperUsers. More work needs to be done to improve cost-effectiveness in IBD care, including reducing the frequency of ED visits.
AB - Background: Inflammatory bowel disease (IBD) is associated with significant psychosocial, economic, and physical burden on patients. IBD care in the United States results in significant healthcare expenditure with recurring emergency department (ED) care and hospital admissions. Despite advances in therapy and improved access to specialty care, there is still room for improvement in cost-efficient care. Specialty medical homes and interdisciplinary care models have emerged as ways to improve medical care, patient outcomes, and quality of life, as well as improve the impact of healthcare costs. There is limited real-world data on cost in the United States, with many articles citing cost estimates from models. Methods: We analyzed real-world data from our tertiary care center with a focus on recurrent ED visits by IBD patients. Descriptive statistics were used for a cost analysis of multiple ED visits by IBD patients. Patients with ≥4 visits to the ED in a 6-month period were described as SuperUsers and were included in a separate analysis. The cost of hospitalization was also included. Results: Total cost associated with all ED visits from SuperUsers were $72 999.57 with an average of $6636.32 per patient. When the patients were admitted, the total cost of ED visits and hospitalizations was $721 461.52, with an average of $65 587.41 per patient. Conclusions: ED utilization by IBD patients with or without hospitalization is expensive and is typically driven by a cohort of SuperUsers. More work needs to be done to improve cost-effectiveness in IBD care, including reducing the frequency of ED visits.
UR - http://www.scopus.com/inward/record.url?scp=85192866814&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85192866814&partnerID=8YFLogxK
U2 - 10.1093/crocol/otae029
DO - 10.1093/crocol/otae029
M3 - Article
C2 - 38736841
AN - SCOPUS:85192866814
SN - 2631-827X
VL - 6
JO - Crohn's and Colitis 360
JF - Crohn's and Colitis 360
IS - 2
M1 - otae029
ER -